Purespring Advances PS-003 Gene Therapy Toward the Clinic
Purespring Therapeutics said it presented new preclinical and epidemiological data on PS-003 for X-linked Alport Syndrome at ASN Kidney Week 2026.
Purespring Therapeutics said it presented new preclinical and epidemiological data on PS-003 for X-linked Alport Syndrome at ASN Kidney Week 2026.